BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer

被引：16
|
作者：
Gross, Amy L. [1 ]
Blot, William J. [2 ]
Visvanathan, Kala [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 06期
关键词：
D O I：
10.1001/jama.2018.8258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [21] BRCA2 AND BRCA1 breast cancer phenotypes
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Tonin, P
    Serova, O
    Lenoir, GM
    Lynch, HT
    LABORATORY INVESTIGATION, 1997, 76 (01) : 110 - 110
  • [22] Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: A decision analysis
    Tengs, TO
    Winer, EP
    Paddock, S
    Aguilar-Chavez, O
    Berry, DA
    MEDICAL DECISION MAKING, 1998, 18 (04) : 365 - 375
  • [23] BRCA1 and BRCA2 Testing Among Young Breast Cancer Survivors
    Kehl, Kenneth L.
    Giordano, Sharon H.
    JAMA ONCOLOGY, 2016, 2 (05) : 688 - +
  • [24] BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Gelber, Shari
    Schapira, Lidia
    Come, Steven
    Borges, Virginia F.
    Larsen, Bryce
    Garber, Judy E.
    Partridge, Ann H.
    JAMA ONCOLOGY, 2016, 2 (06) : 730 - 736
  • [25] Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families
    de Bock, G.
    van der Kolk, D.
    Schaapveld, M.
    Jansen, L.
    Mourits, M. J.
    Oosterwijk, J. C.
    EJC SUPPLEMENTS, 2010, 8 (03): : 224 - 224
  • [26] BRCA1 and BRCA2 Mutations in Ovarian Cancer Reply
    Zhang, Wei
    Yang, Da
    Sood, Anil K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 360 - 361
  • [27] BRCA1 and BRCA2 as ovarian cancer susceptibility genes
    Sowter, HM
    Ashworth, A
    CARCINOGENESIS, 2005, 26 (10) : 1651 - 1656
  • [28] A state by state analysis of BRCA1 and BRCA2 testing in patients with ovarian cancer
    Herzog, T. J.
    Saam, J.
    Arnell, C.
    Wenstrup, R. J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 178 - 178
  • [29] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [30] Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2
    Hoang, Lien N.
    Gilks, Blake C.
    ADVANCES IN ANATOMIC PATHOLOGY, 2018, 25 (02) : 85 - 95
12345